Hester Biosciences consolidated net profit declines 20.33% in the March 2022 quarter

20 May 2022 , 01:46 PM

Net profit of Hester Biosciences declined 20.33% to Rs 7.72 crore in the quarter ended March 2022 as against Rs 9.69 crore during the previous quarter ended March 2021. Sales declined 12.01% to Rs 56.47 crore in the quarter ended March 2022 as against Rs 64.18 crore during the previous quarter ended March 2021. For the full year,net profit rose 14.20% to Rs 39.32 crore in the year ended March 2022 as against Rs 34.43 crore during the previous year ended March 2021. Sales rose 9.65% to Rs 235.01 crore in the year ended March 2022 as against Rs 214.33 crore during the previous year ended March 2021.

Particulars	Quarter Ended	Year Ended
?	Mar. 2022	Mar. 2021	% Var.	Mar. 2022	Mar. 2021	% Var.
Sales	56.47	64.18	-12	235.01	214.33	10
OPM %	18.28	30.80	–	25.53	32.03	–
PBDT	16.44	20.82	-21	70.08	66.74	5
PBT	11.31	17.19	-34	53.50	53.42	0
NP	7.72	9.69	-20	39.32	34.43	14

Powered by Capital Market – Live News